The title is little tricky.
Aldosterone known to cause sodium retention and potassium depletion. This maybe true for blood but not cellular.
Na-K-ATPase is an enzyme that responsible for promoting potassium, depleting sodium.
This study shows that aldosterone actually increased Na-K-ATPase enzyme and decreased intracellular sodium. Spironolactone blocked this effect and promoted intracellular sodium.
Digoxin, another heart failure drug, known to inhibit Na-K-ATPase and promote sodium retention.
Effect of Spironolactone on Cytosolic Free Sodium Concentration in Platelets From Hypertensive Patients With Primary Aldosteronism - PubMed
[Na+]i was significantly decreased in platelets from patients with primary aldosteronism compared to control subjects.
From the present results it may be concluded that intracellular sodium is decreased by aldosterone-induced activation of Na-K-ATPase. That activation may be partly blocked by spironolactone.
Aldosterone known to cause sodium retention and potassium depletion. This maybe true for blood but not cellular.
Na-K-ATPase is an enzyme that responsible for promoting potassium, depleting sodium.
This study shows that aldosterone actually increased Na-K-ATPase enzyme and decreased intracellular sodium. Spironolactone blocked this effect and promoted intracellular sodium.
Digoxin, another heart failure drug, known to inhibit Na-K-ATPase and promote sodium retention.
Effect of Spironolactone on Cytosolic Free Sodium Concentration in Platelets From Hypertensive Patients With Primary Aldosteronism - PubMed
[Na+]i was significantly decreased in platelets from patients with primary aldosteronism compared to control subjects.
From the present results it may be concluded that intracellular sodium is decreased by aldosterone-induced activation of Na-K-ATPase. That activation may be partly blocked by spironolactone.